A call to invest in immunological determinants of pediatric post‐COVID conditions: Insights from a post‐COVID pANCA+ diffuse alveolar hemorrhage in an adolescent
Open Access
- 17 August 2022
- journal article
- letter
- Published by Wiley in Pediatric Pulmonology
- Vol. 57 (11) , 2861-2862
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signaturesAllergy, 2022
- Long-Term Outcomes of Pediatric Infections: From Traditional Infectious Diseases to Long CovidFuture Microbiology, 2022
- Comparison of Seroconversion in Children and Adults With Mild COVID-19JAMA Network Open, 2022
- Assessing the impact of the pandemic in children and adolescents: SARS-CoV-2 infection and beyondThe Lancet Child & Adolescent Health, 2022
- Long COVID in childrenThe Lancet Child & Adolescent Health, 2021
- Pediatric P‐ANCA vasculitis following COVID‐19Pediatric Pulmonology, 2021
- Acute ANCA Vasculitis and Asymptomatic COVID-19Pediatrics, 2021
- Anti-Neutrophilic Cytoplasmic Antibody (ANCA) Vasculitis Presented as Pulmonary Hemorrhage in a Positive COVID-19 Patient: A Case ReportCureus, 2020
- Diffuse Alveolar HemorrhageTuberculosis and Respiratory Diseases, 2013